ClinicalTrials.gg
CompletedNCT05036642Updated Oct 25, 2023Results posted

Effects of Post-Stroke Upper Extremity Assistance

An interventional study of Compliant Passive Arm Support in Arm Weakness as a Consequence of Stroke, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-25.

Sponsored by Stanford University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to quantify the improvement of post- stroke individuals' ability to move their arms during and after robot assisted therapy.

While researchers know that robot assisted therapies improve motor performance over the course of weeks, they do not know how motor performance is affected over the course of minutes or hours. A better understanding of how robot assisted therapies affect motor performance on short time scales may help us to prescribe more effective therapy doses to maximize motor recovery after neurological injury.

The study will allow us to obtain a detailed understanding of the performance of the device as described above.

02

Conditions studied

  • Arm Weakness as a Consequence of Stroke
03

In context

Lead sponsor

Stanford University is the lead sponsor of 2,162 studies on the registry; 429 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • greater than 6 months post-stroke
  • passive abduction to 90 degrees at shoulder
  • reduced active (retro)flexion/extension at shoulder when abducted at 90 degrees
  • reduced active flexion/extension at elbow

Exclusion criteria

Exclusion Criteria:

  • unable to give informed consent
  • unable to comprehend and follow instructions
  • have a condition (other than stroke) affecting sensorimotor function
  • show evidence of unilateral spatial neglect
  • unable to sit in a chair without armrests for 2 hours
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Stroke Survivors

    Stroke survivors with upper extremity motor impairments

    Device: Compliant Passive Arm Support

Interventions

  • DeviceCompliant Passive Arm Support

    The device is a mechanical device that consists of two linkages, elastic bands, a commercial posture brace, and a hook-and-loop fastener. The design of the device, with several compliant elements, ensures that one device fits many without joint alignment concerns. No motors or other actuators add energy into the system, meaning that it is stable.

06

What researchers measure

Primary outcomes

  1. Wolf Motor Function Test - Change in Functional Score by Task (WMFT)

    Change reported as number of tasks where participants on average had increased functionality, no change, or decreased functionality. Lower functional scores are indicative of lower functional levels. The WMFT consists of 17 tasks: Forearm to table (side), Forearm to box (side), Extend elbow (to the side), Extend elbow (to the side) - with weight, Hand to table (front), Hand to box (front), Weight to box, Reach and retrieve, Lift can, Lift pencil, Lift paper clip, Stack checkers, Flip cards, Grip Strength, Turning key In lock, Fold towel, and Lift basket. Fifteen tasks were assessed for this outcome: task 7 (Weight to box) is reported in a separate analysis; task 14 (Grip strength) was excluded due to an inability to acquire the necessary equipment.

    Time frame: Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.

  2. Wolf Motor Function Test - Change in Completion Time by Task

    Change reported as number of tasks which participants on average performed with increased time, no change, or decreased time. If a participant was unable to complete the task, a time score of 120+ seconds was assigned and converted to 121 for calculation purposes. The WMFT consists of 17 tasks: Forearm to table (side), Forearm to box (side), Extend elbow (to the side), Extend elbow (to the side) - with weight, Hand to table (front), Hand to box (front), Weight to box, Reach and retrieve, Lift can, Lift pencil, Lift paper clip, Stack checkers, Flip cards, Grip Strength, Turning key In lock, Fold towel, and Lift basket. Fifteen tasks were assessed for this outcome: task 7 (Weight to box) is reported in a separate analysis; task 14 (Grip strength) was excluded due to an inability to acquire the necessary equipment.

    Time frame: Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.

  3. Wolf Motor Function Test - Weight Lifted

    Weight lifted (carried) in task 7 of the WMFT: Weight to box. In this assessment, the participant is seated and lifts weight to a box centered on a table in front of them, while keeping his/her back against the chair.

    Time frame: Assessed at baseline (without the device) and after approximately 5 minutes of use with the device.

  4. Percentage of Successful Motions

    Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. The participant was asked to perform 6 motions (3 clockwise and 3 counterclockwise in randomized order). This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. Successful motion is defined as motion where any part of the arm is within 20cm of shoulder level. The percentage of motion in which successful motion occurred over the total motion was reported.

    Time frame: Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.

  5. Reachable Workspace - Mean Distance From Trunk, Successful Motions

    Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. Successful motion is defined as motion where any part of the arm is within 20cm of shoulder level. The distance from the wrist to the trunk was reported for successful motion. Distance closer to the trunk indicates greater ability to correctly perform the task. Negative numbers would indicate the arm was below the trunk; positive numbers would indicate the arm was above the trunk.

    Time frame: Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.

  6. Reachable Workspace - Area, Successful Motions

    Participants will be instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. A larger workspace area indicates fewer upper extremity motor impairments.

    Time frame: Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.

  7. Reachable Workspace - Mean Distance From Trunk, All Motions

    Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. The distance from the wrist to the trunk was reported for all motion. Distance closer to the trunk indicates greater ability to correctly perform the task. Negative numbers would indicate the arm was below the trunk; positive numbers would indicate the arm was above the trunk.

    Time frame: Assessed at baseline (without the device) and after approximately 60 minutes of use with the device.

Secondary outcomes

  1. Participant Satisfaction Survey

    Closing survey of participants satisfaction with the device (impact, comfort, and responsiveness). Participants rated the experience as very positive, positive, neutral, negative, or very negative.

    Time frame: After study procedures have been performed, on day 2 (up to 5 minutes to complete survey)

07

Results

Posted Oct 25, 2023

Participant flow

Pilot Phase
Participant flow — Pilot Phase
MilestonePilot PhaseEvaluation Phase
Started10
Completed10
Not completed00
Evaluation Phase
Participant flow — Evaluation Phase
MilestonePilot PhaseEvaluation Phase
Started011
Completed011
Not completed00

Outcome measures

PrimaryWolf Motor Function Test - Change in Functional Score by Task (WMFT)

Change reported as number of tasks where participants on average had increased functionality, no change, or decreased functionality. Lower functional scores are indicative of lower functional levels. The WMFT consists of 17 tasks: Forearm to table (side), Forearm to box (side), Extend elbow (to the side), Extend elbow (to the side) - with weight, Hand to table (front), Hand to box (front), Weight to box, Reach and retrieve, Lift can, Lift pencil, Lift paper clip, Stack checkers, Flip cards, Grip Strength, Turning key In lock, Fold towel, and Lift basket. Fifteen tasks were assessed for this outcome: task 7 (Weight to box) is reported in a separate analysis; task 14 (Grip strength) was excluded due to an inability to acquire the necessary equipment.

Time frame:
Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.
Reported as:
Count of units · Tasks
Wolf Motor Function Test - Change in Functional Score by Task (WMFT)
TasksEvaluation Phase
Increase functionality7
No change3
Decreased functionality5
PrimaryWolf Motor Function Test - Change in Completion Time by Task

Change reported as number of tasks which participants on average performed with increased time, no change, or decreased time. If a participant was unable to complete the task, a time score of 120+ seconds was assigned and converted to 121 for calculation purposes. The WMFT consists of 17 tasks: Forearm to table (side), Forearm to box (side), Extend elbow (to the side), Extend elbow (to the side) - with weight, Hand to table (front), Hand to box (front), Weight to box, Reach and retrieve, Lift can, Lift pencil, Lift paper clip, Stack checkers, Flip cards, Grip Strength, Turning key In lock, Fold towel, and Lift basket. Fifteen tasks were assessed for this outcome: task 7 (Weight to box) is reported in a separate analysis; task 14 (Grip strength) was excluded due to an inability to acquire the necessary equipment.

Time frame:
Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.
Reported as:
Count of units · Tasks
Wolf Motor Function Test - Change in Completion Time by Task
TasksEvaluation Phase
Increased time3
No change0
Decreased time12
PrimaryWolf Motor Function Test - Weight Lifted

Weight lifted (carried) in task 7 of the WMFT: Weight to box. In this assessment, the participant is seated and lifts weight to a box centered on a table in front of them, while keeping his/her back against the chair.

Time frame:
Assessed at baseline (without the device) and after approximately 5 minutes of use with the device.
Reported as:
Mean · pounds
Wolf Motor Function Test - Weight Lifted
poundsEvaluation Phase
No Device4.6 ± 4.8
With Device6.1 ± 4.8
PrimaryPercentage of Successful Motions

Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. The participant was asked to perform 6 motions (3 clockwise and 3 counterclockwise in randomized order). This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. Successful motion is defined as motion where any part of the arm is within 20cm of shoulder level. The percentage of motion in which successful motion occurred over the total motion was reported.

Time frame:
Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.
Reported as:
Mean · percentage of motions
Percentage of Successful Motions
percentage of motionsEvaluation Phase
No device57.5 ± 42.28
With device69.84 ± 45.07
Statistical analysis
  • Evaluation Phase · Wilcoxon (Mann-Whitney) · p = 0.02
PrimaryReachable Workspace - Mean Distance From Trunk, Successful Motions

Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. Successful motion is defined as motion where any part of the arm is within 20cm of shoulder level. The distance from the wrist to the trunk was reported for successful motion. Distance closer to the trunk indicates greater ability to correctly perform the task. Negative numbers would indicate the arm was below the trunk; positive numbers would indicate the arm was above the trunk.

Time frame:
Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.
Reported as:
Mean · meters
Reachable Workspace - Mean Distance From Trunk, Successful Motions
metersEvaluation Phase
No device-0.07 ± 0.07
With device-0.05 ± 0.07
Statistical analysis
  • Evaluation Phase · ANOVA · p = 0.01
PrimaryReachable Workspace - Area, Successful Motions

Participants will be instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. A larger workspace area indicates fewer upper extremity motor impairments.

Time frame:
Assessed at baseline (without the device) and after approximately 30 minutes of use with the device.
Reported as:
Mean · m^2
Reachable Workspace - Area, Successful Motions
m^2Evaluation Phase
No device0.078 ± 0.084
With device0.082 ± 0.073
Statistical analysis
  • Evaluation Phase · Wilcoxon (Mann-Whitney) · p = 0.48
PrimaryReachable Workspace - Mean Distance From Trunk, All Motions

Participants are instructed to individually flex and extend the elbow and shoulder to trace the largest possible circle that they can reach while keeping the hand and elbow raised to the height of the shoulder while the motion of the arm is tracked with motion capture. This protocol was originally developed by Sukal et al (2007); to asses post-stroke motor abilities. The distance from the wrist to the trunk was reported for all motion. Distance closer to the trunk indicates greater ability to correctly perform the task. Negative numbers would indicate the arm was below the trunk; positive numbers would indicate the arm was above the trunk.

Time frame:
Assessed at baseline (without the device) and after approximately 60 minutes of use with the device.
Reported as:
Mean · meters
Reachable Workspace - Mean Distance From Trunk, All Motions
metersEvaluation Phase
No device-0.14 ± 0.12
With device-0.12 ± 0.12
SecondaryParticipant Satisfaction Survey

Closing survey of participants satisfaction with the device (impact, comfort, and responsiveness). Participants rated the experience as very positive, positive, neutral, negative, or very negative.

Time frame:
After study procedures have been performed, on day 2 (up to 5 minutes to complete survey)
Reported as:
Count of participants · Participants
Participant Satisfaction Survey
ParticipantsVery PositivePositiveNeutralNegativeVery Negative
Impact34111
Comfort41050
Responsiveness26200

Adverse events

Collected over 2 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pilot Phase0/1 (0%)0/1 (0%)0/1 (0%)
Evaluation Phase0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Pilot PhaseEvaluation PhaseTotal
<=18 years000
Between 18 and 65 years044
>=65 years178
Sex: Female, Male
Sex: Female, Male(Participants)Pilot PhaseEvaluation PhaseTotal
Female033
Male189
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Pilot PhaseEvaluation PhaseTotal
Hispanic or Latino000
Not Hispanic or Latino11112
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Pilot PhaseEvaluation PhaseTotal
American Indian or Alaska Native000
Asian055
Native Hawaiian or Other Pacific Islander000
Black or African American000
White156
More than one race011
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Pilot PhaseEvaluation PhaseTotal
United States11112
08

Study locations

1 site
  • Stanford University CHARM Lab
    Stanford, California 94305, United States
09

References and documents

Publications

  • Sukal TM, Ellis MD, Dewald JP. Shoulder abduction-induced reductions in reaching work area following hemiparetic stroke: neuroscientific implications. Exp Brain Res. 2007 Nov;183(2):215-23. doi: 10.1007/s00221-007-1029-6. Epub 2007 Jul 20. PubMed 17634933 ↗

Study documents

  • Study protocol · Jul 8, 2022
  • Statistical analysis plan · Sep 6, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2022 to primary completion in Sep 2022, 1 month.

Results were first posted in Oct 2023, 1 year 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2021
First posted
Sep 5, 2021
StartActual
Jul 26, 2022
Primary completionActual
Sep 7, 2022
CompletionActual
Sep 7, 2022
Results first posted
Oct 25, 2023
Last update
Oct 25, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05036642
Responsible party
Allison Okamura (Professor of Mechanical Engineering, Stanford University) — Principal investigator
First posted
Sep 5, 2021
Start date
Jul 26, 2022
Primary completion
Sep 7, 2022
Completion
Sep 7, 2022
Results posted
Oct 25, 2023
Last update
Oct 25, 2023

Study contacts

Allison Okamura
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion